trending Market Intelligence /marketintelligence/en/news-insights/trending/stio__y67ig5q8x5pmt57g2 content esgSubNav
In This List

Aurinia Pharmaceuticals appoints director

Blog

Global Capital Markets & SPAC Activity – H1 2021

Blog

Gauging Supply Chain Risk In Volatile Times

Blog

Insight Weekly: Banks' efficiency push; vacuuming carbon; Big Pharma diversity goals

Blog

The Future of Risk Management Digitization in Credit Risk Management


Aurinia Pharmaceuticals appoints director

Canada's Aurinia Pharmaceuticals Inc. added Michael Hayden to its board.

Hayden most recently served as president of global research and development and chief scientific officer at Teva Pharmaceutical Industries Ltd.